secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0000310764-25-000103
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q2 2025: net sales $6.0B +11.1%, adj EPS $3.13 +11.4%, raises FY guidance
--------------------------------------------------------------------------------

- Net sales $6.0B +11.1% reported (+10.2% organic); MedSurg/Neuro +17.3%, Orthopaedics +2.0% (ex-spinal +10.7%).
- Reported EPS $2.29 +7.0%; adjusted EPS $3.13 +11.4%. Adj. operating margin 25.7% +110 bps.
- FY 2025 guidance raised: organic sales growth 9.5-10.0%, adj EPS $13.40-$13.60.
- Tariff impact estimated at ~$175M net, reflecting US-China reduction and proposed US-EU framework.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076425000103/0000310764-25-000103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076425000103/syk-20250731.htm
  HTML page:      https://secwatch.observer/filing/0000310764-25-000103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer